Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $ 4000.00 | Pages : 424 | Published : May 2020 | SKU CODE : o&s134 | Format :

Request Sample

Ophthalmology Drugs Market Definition

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. The ophthalmology drugs industry includes establishments that produce pharmaceutical drugs to treat glaucoma diseases, anti- inflammatory and tear stimulating drugs under dry eye medications drugs, and other drugs for treating retinal disorders and allergies. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.

The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Ophthalmologic drug manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.  

Ophthalmology Drugs Market Size

The global ophthalmology drugs market is expected to decline from $24,640.0 million in 2019 to $19,831.3 million in 2020 at a compound annual growth rate (CAGR) of -19.5%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 44.6% from 2021 and reach $33,272.8 million in 2023. The market is expected to grow at a CAGR of 7.2% to nearly $38,223.53 million by 2025, and at a CAGR of 7.0% to $53,698.87 million by 2030.  

Growth in the historic period resulted from the aging population prone to age related eye disorders, increase number of contact lens users suffering from dry eye condition, increased funding from public and private research organizations, increased healthcare expenditure globally, increase in allergy diseases (hay fever) and increase in number of treatment options. Factors that negatively affected growth in the historic period were low healthcare access, particularly in developing countries, and lack of awareness about eye disorders such as dry eye and glaucoma.

Going forward, rise in laser surgeries, digitalization of the workplace, increasing prevalence of eye-related disorders and increasing geriatric population, growing burden of the diabetes and other comorbidities, side effects of other medication, and promising pipeline for dry eye disease will drive growth. Factors that could hinder the growth of the ophthalmology drugs market in the future include long and costly drug approval procedures, inadequate insurance coverage of ophthalmologists’ services expiration of branded drug patents and disruption in the supply chain of ophthalmology drugs due to the impact of covid-19.

Ophthalmology Drugs Market Drivers

The key drivers of the ophthalmology drugs market include:

Increasing Prevalence Of Eye-Related Disorders

Increasing incidence and prevalence of eye diseases causing vision loss or blindness and age-related eye diseases is expected to support the growth of the ophthalmic drugs market. Eye disorders such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and cataract are becoming major causes of visual impairment and blindness globally. Globally, AMD ranks the third cause of blindness after cataract and glaucoma.lxxix It is estimated that AMD, on average, affects an estimated 34 million people in the European Union (EU) with 22 million people, in the five most populous European countries alone. It is expected that there will be a 25% rise in AMD patient population by 2050 owing to the population growth and aging. By 2050, an estimated 7.32 million people in the USA are expected to have primary open angle glaucoma (POAG), a rise from 3.15 million in 2015.lxxx There has also been a rise in diabetic retinopathy largely due to the spike in diabetes across the world. It is estimated that more than 25% of diabetic patients are expected to have diabetic retinopathy going forwardlxxxi. The increasing incidence and prevalence of eye-related disorders is expected to drive the ophthalmology drugs market.

Ophthalmology Drugs Market Restraints

The key restraints on the ophthalmology drugs market include:

Inadequate Insurance Coverage

Inadequate social protection in health is expected to be one of the major barriers for the growth of the ophthalmology drugs market. According to 2015 report released by WHO and the World Bank, 400 million people worldwide do not have access to essential health services and 6% of people in low- and middle-income countries are tipped into or pushed further into extreme poverty because of health spending.lxxxviii Eye care is not hospital-based, nor does it constitute a huge portion of commercial insurance portfolios making ophthalmology not the first priority for healthcare insurance.lxxxix In the USA, the new guidelines of the Affordable Care Act (ACA) increased deductibles of healthcare insurance plans as high as $6,500 for an individual and $12,700 for a family without covering the full treatment prescribed by an ophthalmologist, pushing patients to skip their routine checkups or follow-up visits. Additionally, prices of some glaucoma medications increased from $5 for a generic to $50xc. Inadequate insurance coverage is expected to restraint the ophthalmology drugs market going forward.

Ophthalmology Drugs Market Trend

Major trends influencing the ophthalmology drugs market include:

Development Of New Mode Of Delivery Systems

Dry eye drug manufacturing companies are attempting to develop dry eye care products in various delivery systems to ensure improved patient compliance and usage along with profitability for the companies. Hence the introduction of new mode of delivery systems such as eye sprays for immediate comfort and improved patient compliance. Eye spray improves eyelids humidification, which serves as a substitute for people avoiding eye drops. For instance, Candorvision unveiled the CALMO Eye Spray, the first free eye preservative spray to be sold in Canada. CALMO Eye Spray repairs and stabilizes the tear film`s lipid layer with its German liposome technology, and thus effectively solves one of the root causes of dry eye syndrome.  

Development Of Combination Therapies

Development of combination therapies for the treatment of dry eye related diseases is an emerging trend in the dry-eye medication market. Combination therapy involves the use of more than one medication or drug to treat a disease. These combinational therapies reduce the frequency of administration of eye drops or drugs, and reduce the possibility of vascular endothelial growth factor (VEGF) expression, choroidal neovascularization and inflammation.  

Opportunities And Recommendations In The Ophthalmology Drugs Market

Opportunities – The top opportunities in the ophthalmology drugs market segmented by type of drug will arise in the other ophthalmology drugs segment, which will gain $5,975.5 million of global annual sales by 2023. The top opportunities in the ophthalmology drugs market segmented by distribution channel will arise in the retail pharmacies segment, which will gain $4,580.4 million of global annual sales by 2023. The top opportunities in the ophthalmology drugs market segmented by prescription type will arise in the prescription drugs segment, which will gain $5,216.39 million of global annual sales by 2023. The top opportunities in the ophthalmology drugs market segmented by drug variation will arise in the generic drugs segment, which will gain $5,430.37 million of global annual sales by 2023.

The ophthalmology drugs market size will gain the most in USA at $3,838 million. Market-trend-based strategies for the ophthalmology drugs market include develop innovative drugs, develop drugs with rho-kinase inhibitors to make the glaucoma drugs more effective, develop preservative free eye drops for the treatment of dry-eye syndrome, develop new mode of delivery systems for the treatment of dry-eye syndrome, invest in research and development of new and advanced drugs, develop non-steroidal anti-inflammatory ophthalmic drugs, develop combination therapies and consider acquiring smaller companies to diversify their product portfolio. Player-adopted strategies in the ophthalmology drugs market include expanding through acquisitions, expanding its ophthalmic products to newer geographies by obtaining drug approvals from regulatory authorities, and aim at building diverse ophthalmology portfolio with a pipeline of drugs.

Recommendations – To take advantage of the opportunities, The Business Research Company recommends the ophthalmology drug manufacturing companies to focus on developing non-steroidal anti-inflammatory drugs (NSAIDs), invest in innovations and research and development, focus on developing innovative drugs for postoperative inflammation and pain, offer competitive or reference pricing, offer skimming price for branded drugs, expand to low cost countries, scale up through collaborations, use direct-to-consumer (DTC) advertising and use big data analytics to improve marketing activities.

Ophthalmology Drugs Market Segmentation

The ophthalmology market is segmented by drug type, prescription type, distribution channel, drug variation and by geography.
By Drug Type- The ophthalmology drugs market can be segmented by drug type
    • a) Antiglaucoma Drugs
    • b) Dry Eye Medication
    • c) Other Ophthalmology Drugs
The ophthalmology drugs market is segmented by drug type into antiglaucoma drugs, dry eye medication and other ophthalmology drugs used to treat retinal disorders, infections and allergies. The other ophthalmology drugs market was the largest segment of the ophthalmology market, accounting for 58.1% of the total in 2019. It was followed by antiglucoma drugs and dry eye medication. Going forward, the other ophthalmology drugs segment is expected to be the fastest growing segment in the ophthalmology market, at a CAGR of 9.1%.
By Prescription Type- The ophthalmology drugs market can be segmented by prescription type
    • a) OTC Drugs
    • b) Prescription Drugs
The ophthalmology drugs market is segmented by prescription type into OTC drugs and prescription drugs. The OTC drugs market was the largest segment of the ophthalmology market segmented by prescription type, accounting for 54.1% of the total in 2019. Going forward, the prescription drugs segment is expected to be the fastest growing segment in the ophthalmology drugs market segmented by prescription type, at a CAGR of 9.9%.
By Distribution Channel- The ophthalmology drugs market can be segmented by distribution channel
    • a) Hospital Pharmacies
    • b) Eye Health Clinics
    • c) Retail Pharmacies
    • d) Online Pharmacies
The ophthalmology drugs market is segmented by distribution channel into hospital pharmacies, eye health clinics, retail pharmacies and online pharmacies. The retail pharmacies was the largest segment of the ophthalmology drugs market segmented by type of distribution channel, accounting for 63.0% of the total in 2019. Online pharmacies segment is expected to be the fastest growing segment in the ophthalmology drugs market segmented by type of distribution channel, at a CAGR of 15.4%.
By Drug Variation- The ophthalmology drugs market can be segmented by drug variation
    • a) Branded Drugs
    • b) Generic Drugs
The ophthalmology drugs market is segmented by drug variation into branded drugs and generic drugs. The branded drugs was the largest segment of the ophthalmology drugs market segmented by drug variation, accounting for 50.8% of the total in 2019. Generic drugs segment is expected to be the fastest growing segment in the ophthalmology drugs market segmented by drug variation, at a CAGR of 9.7%.
By Geography– The ophthalmology drugs market is segmented into
    • o North America
      • USA
      • Canada
      • Mexico
    • o Western Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
      • Denmark
      • Switzerland
      • Ireland
      • Sweden
      • Netherlands
      • Austria
      • Belgium
      • Portugal
      • Norway
      • Finland
    • o Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • Philippines
      • Vietnam
      • Indonesia
      • Malaysia
      • New Zealand
      • Hong Kong
      • Singapore
      • South Korea
      • Thailand
    • o Eastern Europe
      • Poland
      • Russia
      • Romania
      • Czech Republic
    • o South America
      • Peru
      • Argentina
      • Chile
      • Brazil
      • Colombia
      • Venezuela
    • o Middle East
      • Saudi Arabia
      • UAE
      • Turkey
      • Israel
    • o Africa
      • Nigeria
      • Egypt
      • South Africa
North America was the largest region in the global ophthalmology drugs market, accounting for 41.4% of the total in 2019. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the ophthalmology drugs market will be North America and Asia Pacific, where growth will be at CAGRs of 8.9% and 8.5% respectively. These will be followed by Western Europe and South America, where the markets are expected to grow at CAGRs of 5.4% and 4.7% respectively.

Ophthalmology Drugs Competitive Landscape

Major Competitors are:
    • • Novartis AG
    • • Regeneron Pharmaceuticals, Inc.
    • • Allergan plc
    • • Bayer AG
    • • Santen Pharmaceutical Co., Ltd.
Other Competitors Include:
    • • Shanghai Pharmaceuticals
    • • Johnson & Johnson
    • • Bayer AG
    • • Pfizer
    • • Sun Pharma
    • • Otsuka Pharmaceutical Co. Ltd
    • • Daiichi Sankyo
    • • ERC Labs
    • • Vision gain
    • • Medicom Health care
    • • Implandata ophthalmic products GmbH
    • • The Geuder Group, MORCHER® GmbH
    • • Novamedika
    • • Aflofarm Farmacja Polska Sp. z o. o,
    • • Alcon Pharmaceuticals Czech Republic S.r.o.
    • • VUAB Pharma, Inc
    • • Endo International plc
    • • Aurinia Pharmaceuticals Inc
    • • Herzig Eye Institute
    • • Thomas Eye Group
    • • ReGenTree, LLC
    • • Regenerx Biopharmaceuticals Inc
    • • Shire
    • • Teuto Brasileiro
    • • Biolab Farmaceutica
    • • Cristalia
    • • Roche
    • • Adcock Ingram

  1. 1. Ophthalmology Drugs Market Executive Summary
  2. 2. Table of Contents
  3. 3. List of Figures
  4. 4. List of Tables
  5. 5. Report Structure
  6. 6. Introduction
    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Drug Type
    • 6.1.3. Segmentation By Prescription Type
    • 6.1.4. Segmentation By Drug Variation
    • 6.1.5. Segmentation By Distribution Channel
  7. 7. Ophthalmology Drugs Market Characteristics
    • 7.1. Market Definition
    • 7.2. Market Segmentation By Drug Type
      • 7.2.1. Antiglaucoma Drugs
      • 7.2.2. Dry Eye Medication
      • 7.2.3. Other Ophthalmological Drugs
    • 7.3. Market Segmentation By Prescription Type
      • 7.3.1. OTC Drugs
      • 7.3.2. Prescription Drugs
    • 7.4. Market Segmentation By Drug Variation
      • 7.4.1. Branded Drugs
      • 7.4.2. Generic Drugs
    • 7.5. Market Segmentation By Distribution Channel
      • 7.5.1. Hospital Pharmacies
      • 7.5.2. Eye Health Clinics
      • 7.5.3. Retail Pharmacies
      • 7.5.4. Online Pharmacies
  8. 8. Ophthalmology Drugs Market Product Analysis – Product Examples
    • 8.1. Leading Products
      • 8.1.1. Novartis AG
      • 8.1.2. Roche
      • 8.1.3. Allergan
      • 8.1.4. Valeant (Bausch+Lomb)
      • 8.1.5. Aerie Pharmaceuticals Inc.
      • 8.1.6. Regeneron Pharmaceuticals Inc.
      • 8.1.7. Pfizer, Inc.
      • 8.1.8. Santen Pharmaceutical Co., Ltd
      • 8.1.9. Genentech, Inc.
      • 8.1.10. Sun Pharmaceuticals Industries, Ltd.
    • 8.2. New Products Approved
      • 8.2.1. Sun
      • 8.2.2. Pharmaceuticals Industries, Ltd.
      • 8.2.3. Dompé
      • 8.2.4. Farmaceutici SpA
      • 8.2.5. EyePoint
      • 8.2.6. Pharmaceuticals,
      • 8.2.7. Inc.
      • 8.2.8. Ivantis
      • 8.2.9. Sun
      • 8.2.10. Pharmaceuticals Industries, Ltd
      • 8.2.11. Regeneron
      • 8.2.12. Kala
      • 8.2.13. Pharmaceuticals
      • 8.2.14. Ocular Therapeutix
      • 8.2.15. EyePoint Pharmaceuticals
      • 8.2.16. Novartis
      • 8.2.17. Aerie Pharmaceuticals
      • 8.2.18. Merz Pharma
  9. 9. Ophthalmology Drugs Market Supply Chain Analysis
    • 9.1. Raw Material Suppliers
    • 9.2. Contract Research Organization (CRO)
    • 9.3. Ophthalmology Drugs Manufacturer
      • 9.3.1. Drug Discovery
      • 9.3.2. Preclinical And Clinical Trials
      • 9.3.3. Patents Upon Discovery And Approval
      • 9.3.4. Drug Manufacturing
    • 9.4. Contract Manufacturing Organization (CMO)
    • 9.5. Wholesalers/Distributors
    • 9.6. Retailers (Pharmacies) And Hospitals
    • 9.7. Ophthalmologists And Optometrists
    • 9.8. End-Users
  10. 10. Ophthalmology Drugs Market Customer Information
    • 10.1. Loss Of Vision Is The Major Concern For Glaucoma Patients
    • 10.2. Majority Of The Patients Do not Seek Preventive Eye Care
    • 10.3. Impact Of Dry Eye Disease (DED) On Patients’ Quality Of Life
    • 10.4. Two-thirds Of Americans Suffer From Eye Problems
    • 10.5. Americans Taking More Prescription Drugs than Ever
    • 10.6. Increasing Intake of Prescription Drugs
  11. 11. Ophthalmology Drugs Market Trends And Strategies
    • 11.1. Innovative Drugs To Reduce Postoperative Inflammation And Pain
    • 11.2. New Rho-kinase Inhibitors for Glaucoma
    • 11.3. Development Of New Mode Of Delivery Systems
    • 11.4. Single Dose Preservative Free Eye Drops
    • 11.5. New Product Development
    • 11.6. Development Of Combination Therapies
    • 11.7. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Dry Eye Treatment
    • 11.8. Rising Research And Collaborations
    • 11.9. Global Expansion And Acquisitions
  12. 12. Leading Ophthalmologic Drug Therapies
  13. 13. Gene Therapy In Ophthalmology
    • 13.1. Current Scenario Of Research And Development In Gene Therapy
    • 13.2. Near-Term Potential
    • 13.3. Long-Term Potential
  14. 14. Unmet Needs In Ophthalmology Drugs Market
  15. 15. Impact of COVID-19 On Ophthalmology Drugs Market
  16. 16. Global Ophthalmology Drugs Market Size And Growth
    • 16.1. Historic Market Growth, 2015 – 2019, Value ($ Million)
      • 16.1.1. Drivers Of The Market 2015 – 2019
      • 16.1.2. Aging Population —
      • 16.1.3. Restraints On The Market 2015 – 2019
    • 16.2. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
      • 16.2.1. Drivers Of The Market 2019 – 2023
      • 16.2.2. Restraints On The Market 2019 – 2023
  17. 17. Ophthalmology Drugs Market, Regional Analysis
    • 17.1. Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 17.2. Global Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Region
    • 17.3. Global Ophthalmology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region
  18. 18. Global Ophthalmology Drugs Market Segmentation
    • 18.1. Global Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 18.1.1. Antiglaucoma Drugs
      • 18.1.2. Dry Eye Medication
      • 18.1.3. Other Ophthalmology Drugs
    • 18.2. Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 18.2.1. Retail Pharmacies
      • 18.2.2. Hospital Pharmacies
      • 18.2.3. Eye Health Clinics
      • 18.2.4. Online Pharmacies
    • 18.3. Global Ophthalmology Drugs Market, Segmentation By Type Of Prescription, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 18.3.1. OTC Drugs
      • 18.3.2. Prescription Drugs
    • 18.4. Global Ophthalmology Drugs Market, Segmentation By Drug Variation, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 18.4.1. Branded Drugs
      • 18.4.2. Generic Drugs
  19. 19. Global Ophthalmology Drugs Market Comparison with Macro Economic Factors
    • 19.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global
    • 19.2. Per Capita Average Ophthalmology Drugs Market Expenditure, Global
  20. 20. Asia-Pacific Ophthalmology Drugs Market
    • 20.1. Asia-Pacific Ophthalmology Drugs Market Overview
    • 20.2. Region Information
    • 20.3. Market Information
    • 20.4. Background Information
    • 20.5. New Drug Approval
    • 20.6. Government Initiatives
    • 20.7. Regulations
    • 20.8. Regulatory Bodies
    • 20.9. Major Associations
    • 20.10. Corporate Tax Structure
    • 20.11. Taxes Levied
    • 20.12. Investments
    • 20.13. Major Companies
    • 20.14. Asia-Pacific Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.15. Asia-Pacific Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.16. Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.17. Asia- Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.18. Asia-Pacific Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • 20.19. Asia-Pacific Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 20.20. Asia-Pacific Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 20.21. Asia-Pacific Ophthalmology Drugs Market Metrics
    • 20.21.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Asia-Pacific Major Countries
    • 20.22. Asia-Pacific Ophthalmology Drugs Market: Country Analysis
    • 20.23. Australia Ophthalmology Drugs Market
    • 20.24. Australia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.25. Australia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.26. Australia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.27. Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.28. China Ophthalmology Drugs Market
    • 20.29. China Ophthalmology Drugs Market Overview
    • 20.30. Country Information
    • 20.31. Market Information
    • 20.32. Background Information
    • 20.33. New Drug Approval
    • 20.34. Government Initiatives
    • 20.35. Regulations
    • 20.36. Regulatory Bodies
    • 20.37. Major Associations
    • 20.38. Tax Levied
    • 20.39. Corporate Tax Structure
    • 20.40. Investments
    • 20.41. Major Companies
    • 20.42. China Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.43. China Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.44. China Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.45. China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.46. Hong Kong Ophthalmology Drugs Market
    • 20.47. Hong Kong Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.48. Hong Kong Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.49. India Ophthalmology Drugs Market
    • 20.50. India Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.51. India Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.52. India Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.53. India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.54. Indonesia Ophthalmology Drugs Market
    • 20.55. Indonesia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.56. Indonesia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.57. Indonesia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.58. Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.59. Japan Ophthalmology Drugs Market
    • 20.60. Japan Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.61. Japan Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.62. Japan Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.63. Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.64. Malaysia Ophthalmology Drugs Market
    • 20.65. Malaysia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.66. Malaysia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.67. New Zealand Ophthalmology Drugs Market
    • 20.68. New Zealand Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.69. New Zealand Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.70. Philippines Ophthalmology Drugs Market
    • 20.71. Philippines Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.72. Philippines Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.73. Singapore Ophthalmology Drugs Market
    • 20.74. Singapore Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.75. Singapore Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.76. South Korea Ophthalmology Drugs Market
    • 20.77. South Korea Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.78. South Korea Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.79. South Korea Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.80. South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.81. Thailand Ophthalmology Drugs Market
    • 20.82. Thailand Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.83. Thailand Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.84. Vietnam Ophthalmology Drugs Market
    • 20.85. Vietnam Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.86. Vietnam Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
  21. 21. Western Europe Ophthalmology Drugs Market
    • 21.1. Western Europe Ophthalmology Drugs Market Overview
      • 21.1.1. Region Information
      • 21.1.2. Market Information
      • 21.1.3. Background Information
      • 21.1.4. New Drug Approvals
      • 21.1.5. Government Initiatives
      • 21.1.6. Regulations
      • 21.1.7. Major Associations
      • 21.1.8. Taxes Levied
      • 21.1.9. Corporate Tax Structure
      • 21.1.10. Investments
      • 21.1.11. Major Companies
    • 21.2. Western Europe Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.3. Western Europe Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.4. Western Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.5. Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.6. Western Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • 21.7. Western Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 21.8. Western Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 21.9. Western Europe Ophthalmology Drugs Market Metrics
      • 21.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Western Europe Major Countries
    • 21.10. Western Europe Ophthalmology Drugs Market: Country Analysis
    • 21.11. Austria Ophthalmology Drugs Market
    • 21.12. Austria Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.13. Austria Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.14. Belgium Ophthalmology Drugs Market
    • 21.15. Belgium Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.16. Belgium Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.17. Denmark Ophthalmology Drugs Market
    • 21.18. Denmark Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.19. Denmark Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.20. Finland Ophthalmology Drugs Market
    • 21.21. Finland Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.22. Finland Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.23. France Ophthalmology Drugs Market
    • 21.24. France Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.25. France Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.26. France Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.27. France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.28. Germany Ophthalmology Drugs Market
    • 21.29. Germany Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.30. Germany Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.31. Germany Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.32. Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.33. Ireland Ophthalmology Drugs Market
    • 21.34. Ireland Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.35. Ireland Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.36. Italy Ophthalmology Drugs Market
    • 21.37. Italy Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.38. Italy Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.39. Italy Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.40. Italy Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.41. Netherlands Ophthalmology Drugs Market
    • 21.42. Netherlands Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.43. Netherlands Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.44. Norway Ophthalmology Drugs Market
    • 21.45. Norway Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.46. Norway Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.47. Portugal Ophthalmology Drugs Market
    • 21.48. Portugal Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.49. Portugal Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.50. Spain Ophthalmology Drugs Market
    • 21.51. Spain Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.52. Spain Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.53. Spain Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.54. Spain Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.55. Sweden Ophthalmology Drugs Market
    • 21.56. Sweden Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.57. Sweden Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.58. Switzerland Ophthalmology Drugs Market
    • 21.59. Switzerland Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.60. Switzerland Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.61. UK Ophthalmology Drugs Market
    • 21.62. UK Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.63. UK Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.64. UK Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.65. UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  22. 22. Eastern Europe Ophthalmology Drugs Market
    • 22.1. Eastern Europe Ophthalmology Drugs Market Overview
      • 22.1.1. Region Information
      • 22.1.2. Market Information
      • 22.1.3. Background Information
      • 22.1.4. New Drug Approvals
      • 22.1.5. Government Initiatives
      • 22.1.6. Regulations
      • 22.1.7. Regulatory Bodies
      • 22.1.8. Major Associations
      • 22.1.9. Taxes Levied
      • 22.1.10. Corporate Tax Structure
      • 22.1.11. Investments
      • 22.1.12. Major Companies
    • 22.2. Eastern Europe Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.3. Eastern Europe Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.4. Eastern Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.5. Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.6. Eastern Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • 22.7. Eastern Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 22.8. Eastern Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 22.9. Eastern Europe Ophthalmology Drugs Market Metrics
      • 22.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Eastern Europe Major Countries
    • 22.10. Eastern Europe Ophthalmology Drugs Market: Country Analysis
    • 22.11. Czech Republic Ophthalmology Drugs Market
    • 22.12. Czech Republic Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.13. Czech Republic Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.14. Poland Ophthalmology Drugs Market
    • 22.15. Poland Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.16. Poland Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.17. Romania Ophthalmology Drugs Market
    • 22.18. Romania Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.19. Romania Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.20. Russia Ophthalmology Drugs Market
    • 22.21. Russia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.22. Russia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.23. Russia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.24. Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  23. 23. North America Ophthalmology Drugs Market
    • 23.1. North America Ophthalmology Drugs Market Overview
      • 23.1.1. Region Information
      • 23.1.2. Market Information
      • 23.1.3. Background Information
      • 23.1.4. New Drug Approval
      • 23.1.5. Government Initiatives
      • 23.1.6. Regulations
      • 23.1.7. Regulatory Bodies
      • 23.1.8. Major Associations
      • 23.1.9. Tax Levied
      • 23.1.10. Corporate Tax Structure
      • 23.1.11. Investments
      • 23.1.12. Major Companies
    • 23.2. North America Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 23.3. North America Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 23.4. North America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.5. North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.6. North America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • 23.7. North America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 23.8. North America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 23.9. North America Ophthalmology Drugs Market Metrics
      • 23.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, North America Major Countries
      • 23.9.2. North America Ophthalmology Drugs Market: Country Analysis
    • 23.10. Canada Ophthalmology Drugs Market
    • 23.11. Canada Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 23.12. Canada Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 23.13. Mexico Ophthalmology Drugs Market
    • 23.14. Mexico Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 23.15. Mexico Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 23.16. USA Ophthalmology Drugs Market Overview
      • 23.16.1. Country Information
      • 23.16.2. Market Information
      • 23.16.3. Background Information
      • 23.16.4. New Drug Approval
      • 23.16.5. Government Initiatives
      • 23.16.6. Regulations
      • 23.16.7. Regulatory Bodies
      • 23.16.8. Major Associations
      • 23.16.9. Tax Levied
      • 23.16.10. Corporate Tax Structure
      • 23.16.11. Investments
      • 23.16.12. Major Companies
    • 23.17. USA Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 23.18. USA Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 23.19. USA Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.20. USA Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  24. 24. South America Ophthalmology Drugs Market
    • 24.1. South America Ophthalmology Drugs Market Overview
      • 24.1.1. Region Information
      • 24.1.2. Market Information
      • 24.1.3. Background Information
      • 24.1.4. New Drug Approval
      • 24.1.5. Government Initiatives
      • 24.1.6. Regulations
      • 24.1.7. Regulatory Bodies
      • 24.1.8. Major Associations
      • 24.1.9. Tax Levied
      • 24.1.10. Corporate Tax Structure
      • 24.1.11. Investments
      • 24.1.12. Major Companies
    • 24.2. South America Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.3. South America Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.4. South America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.5. South America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.6. South America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • 24.7. South America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 24.8. South America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 24.9. South America Ophthalmology Drugs Market Metrics
      • 24.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, South America Major Countries
    • 24.10. South America Ophthalmology Drugs Market: Country Analysis
    • 24.11. Argentina Ophthalmology Drugs Market
    • 24.12. Argentina Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.13. Argentina Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.14. Chile Ophthalmology Drugs Market
    • 24.15. Chile Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.16. Chile Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.17. Colombia Ophthalmology Drugs Market
    • 24.18. Colombia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.19. Colombia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.20. Brazil Ophthalmology Drugs Market
    • 24.21. Brazil Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.22. Brazil Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.23. Brazil Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.24. Brazil Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.25. Peru Ophthalmology Drugs Market
    • 24.26. Peru Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.27. Peru Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.28. Venezuela Ophthalmology Drugs Market
    • 24.29. Venezuela Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.30. Venezuela Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
  25. 25. Middle East Ophthalmology Drugs Market
    • 25.1. Middle East Ophthalmology Drugs Market Overview
      • 25.1.1. Region Information
      • 25.1.2. Market Information
      • 25.1.3. Background Information
      • 25.1.4. New Drug Approvals
      • 25.1.5. Government Initiatives
      • 25.1.6. Regulations
      • 25.1.7. Regulatory Bodies
      • 25.1.8. Major Associations
      • 25.1.9. Taxes Levied
      • 25.1.10. Corporate Tax Structure
      • 25.1.11. Investments
      • 25.1.12. Major Companies
      • 25.1.13. Competitive Landscape
    • 25.2. Middle East Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 25.3. Middle East Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 25.4. Middle East Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 25.5. Middle East Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 25.6. Middle East Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • 25.7. Middle East Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 25.8. Middle East Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 25.9. Middle East Ophthalmology Drugs Market Metrics
      • 25.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Middle East Major Countries
    • 25.10. Middle East Ophthalmology Drugs Market: Country Analysis
    • 25.11. Israel Ophthalmology Drugs Market
    • 25.12. Israel Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 25.13. Israel Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 25.14. Saudi Arabia Ophthalmology Drugs Market
    • 25.15. Saudi Arabia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 25.16. Saudi Arabia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 25.17. Turkey Ophthalmology Drugs Market
    • 25.18. Turkey Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 25.19. Turkey Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 25.20. UAE Ophthalmology Drugs Market
    • 25.21. UAE Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 25.22. UAE Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
  26. 26. Africa Ophthalmology Drugs Market
    • 26.1. Africa Ophthalmology Drugs Market Overview
      • 26.1.1. Region Information
      • 26.1.2. Market Information
      • 26.1.3. Background Information
      • 26.1.4. New Drug Approvals
      • 26.1.5. Government Initiatives
      • 26.1.6. Regulations
      • 26.1.7. Regulatory Bodies
      • 26.1.8. Major Associations
      • 26.1.9. Taxes Levied
      • 26.1.10. Corporate Tax Structure
      • 26.1.11. Major Companies
    • 26.2. Africa Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 26.3. Africa Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 26.4. Africa Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 26.5. Africa Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 26.6. Africa Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
    • 26.7. Africa Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 26.8. Africa Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 26.9. Africa Ophthalmology Drugs Market Metrics
      • 26.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Africa Major Countries
    • 26.10. Africa Ophthalmology Drugs Market: Country Analysis
    • 26.11. Egypt Ophthalmology Drugs Market
    • 26.12. Egypt Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 26.13. Egypt Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 26.14. Nigeria Ophthalmology Drugs Market
    • 26.15. Nigeria Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 26.16. Nigeria Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 26.17. South Africa Ophthalmology Drugs Market
    • 26.18. South Africa Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 26.19. South Africa Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
  27. 27. Global Ophthalmology Drugs Market Competitive Landscape
    • 27.1. Company Profiles
    • 27.2. Novartis AG
      • 27.2.1. Company Overview
      • 27.2.2. Products And Services
      • 27.2.3. Business Strategy
      • 27.2.4. Financial Overview
    • 27.3. Regeneron Pharmaceuticals Inc.
      • 27.3.1. Company Overview
      • 27.3.2. Products And Services
      • 27.3.3. Business Strategy
      • 27.3.4. Financial Overview
    • 27.4. Allergan Plc.
      • 27.4.1. Company Overview
      • 27.4.2. Products And Services
      • 27.4.3. Business Strategy
      • 27.4.4. Financial Overview
    • 27.5. Bayer AG
      • 27.5.1. Company Overview
      • 27.5.2. Products And Services
      • 27.5.3. Business Strategy
      • 27.5.4. Financial Overview
    • 27.6. Santen Pharmaceutical Co. Ltd.
      • 27.6.1. Company Overview
      • 27.6.2. Products And Services
      • 27.6.3. Business Strategy
      • 27.6.4. Financial Overview
  28. 28. Ophthalmology Drugs Market, Key Mergers And Acquisitions
    • 28.1. Stada Arzneimittel AG Acquired Biopharma LLC
    • 28.2. Fidia Farmaceutici S.P.A. Acquired Ophthalmic Products From Novartis Farma Spain
    • 28.3. Immunovant Sciences Ltd. Merged With Health Sciences Acquisitions Corporation
    • 28.4. Aerie Pharmaceuticals Acquired Avizorex Pharma
    • 28.5. Novartis Acquired Ophthalmic Solution Xiidra From Takeda Pharmaceutical
    • 28.6. Biogen Inc. Acquired Nightstar Therapeutics Limited
    • 28.7. AbbVie Acquired Allergan
    • 28.8. Alcon Acquired Tear Film Innovations, Inc.
    • 28.9. Astellas Pharma Inc. Acquired Quethera Limited
    • 28.10. TWi Pharmaceuticals, Inc. Acquired Synpac-Kingdom Pharmaceutical Co Ltd (SKP)
    • 28.11. Chengdu Kanghong Pharma Acquired IOPtima Ltd. From BioLight
    • 28.12. Horizon Therapeutics Plc Acquired River Vision Development Corp.
    • 28.13. Novartis Acquired Encore Vision
    • 28.14. Astellas Pharma Inc. Acquired Ocata Therapeutics
    • 28.15. Purdue Canada Acquired Merck’s Ophthalmology Portfolio
    • 28.16. Sun Pharmaceutical Industries Limited Acquired InSite Vision Inc.
    • 28.17. Actavis Plc. Acquired Allergan Inc.
    • 28.18. Santen Pharmaceutical Co., Ltd. Acquired Merck’s Ophthalmology Products
    • 28.19. Lupin Limited Acquired Laboratorios Grin
  29. 29. Market Background: Pharmaceutical Drugs Market
    • 29.1. Pharmaceutical Drugs Market Characteristics
    • 29.2. Market Segmentation By Product Type
    • 29.3. Global Pharmaceutical Drugs Market, 2019, By Segment, Value ($ Billion)
    • 29.4. Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast, By Segment
    • 29.5. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
    • 29.6. Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast, By Region
  30. 30. Global Ophthalmology Drugs Market Opportunities And Strategies
    • 30.1. Global Ophthalmology Drugs Market In 2023 – Countries Offering Most New Opportunities
    • 30.2. Global Ophthalmology Drugs Market In 2023 – Segments Offering Most New Opportunities
    • 30.3. Global Ophthalmology Drugs Market In 2023 – Growth Strategies
      • 30.3.1. Market Trend Based Strategies
      • 30.3.2. Competitor Strategies
  31. 31. Ophthalmology Drugs Market, Conclusions And Recommendations
    • 31.1. Conclusions
    • 31.2. Recommendations
      • 31.2.1. Product
      • 31.2.2. Price
      • 31.2.3. Place
      • 31.2.4. Promotion
  32. 32. Appendix
    • 32.1. Market Data Sources
    • 32.2. NAICS Definitions Of Industry Covered In This Report
    • 32.3. Research Methodology
    • 32.4. Currencies
    • 32.5. Research Inquiries
    • 32.6. The Business Research Company
  33. 33. Copyright and Disclaimer

List Of Tables

    Table 1: Global Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 2: Global Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 3: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 4: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 5: Global Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 6: Global Ophthalmology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region
  • Table 7: Global Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 8: Global Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 9: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 10: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11: Global Ophthalmology Drugs Market, Segmentation By Type Of Prescription, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 12: Global Ophthalmology Drugs Market, Segmentation By Type Of Prescription, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 13: Global Ophthalmology Drugs Market, Segmentation By Drug Variation, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 14: Global Ophthalmology Drugs Market, Segmentation By Drug Variation, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 15: Global Ophthalmology Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2023
  • Table 16: Global Ophthalmology Drugs Market, Per Capita Average Ophthalmology Drugs Market Industry Expenditure, 2015 – 2023, ($)
  • Table 17:  Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 18:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 19: Asia-Pacific Total Population Aged 65 And Above, 2015-2019, Thousands
  • Table 20: Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $
  • Table 21: Asia-Pacific Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 22: Asia-Pacific Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 23: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 24: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 25: Asia- Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 26: Asia- Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 27: Asia-Pacific Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Table 28: Asia-Pacific Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 29: Asia-Pacific Ophthalmology Drugs Market, 2019,-2022, Growth And Market Share Comparison, By Country
  • Table 30: Asia-Pacific Per Capita Average Ophthalmology Drugs Expenditure, By Country, 2019, $
  • Table 31: Australia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 32: Australia Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 33: Australia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 34: Australia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 35: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 36: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 37:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 38: China Total Population Aged 65 And Above, 2015-2019, Thousands
  • Table 39: China Per Capita Net Disposable Income, 2015-2019, $
  • Table 40: China Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 41: China Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 42: China Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 43: China Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 44: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 45: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 46: Hong Kong Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 47: Hong Kong Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 48: India Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 49: India Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 50: India Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 51: India Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 52: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 53: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 54: Indonesia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 55: Indonesia Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 56: Indonesia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 57: Indonesia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 58: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 59: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 60: Japan Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 61: Japan Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 62: Japan Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 63: Japan Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 64: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 65: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 66: Malaysia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 67: Malaysia Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 68: New Zealand Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 69: New Zealand Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 70: Philippines Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 71: Philippines Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 72: Singapore Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 73: Singapore Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 74: South Korea Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 75: South Korea Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 76: South Korea Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 77: South Korea Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 78: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 79: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 80: Thailand Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 81: Thailand Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 82: Vietnam Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 83: Vietnam Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 84: Western Europe Total Population Aged 65 And Above, 2015-2019, Thousands
  • Table 85: Taxes Levied On Prescription Drugs In Western European Countries, %
  • Table 86: Western Europe Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 87: Western Europe Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 88: Western Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 89: Western Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 90: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 91: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 92: Western Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Table 93: Western Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 94: Western Europe Ophthalmology Drugs Market, 2019,-2022, Growth And Market Share Comparison, By Country
  • Table 95: Western Europe Per Capita Average Ophthalmology Drugs Expenditure, By Country, 2019, $
  • Table 96: Austria Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 97: Austria Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 98: Belgium Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 99: Belgium Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 100: Denmark Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 101: Denmark Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 102: Finland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 103: Finland Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 104: France Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 105: France Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 106: France Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 107: France Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 108: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 109: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 110: Germany Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 111: Germany Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 112: Germany Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 113: Germany Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 114: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 115: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 116: Ireland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 117: Ireland Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 118: Italy Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 119: Italy Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 120: Italy Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 121: Italy Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 122: Italy Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 123: Italy Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 124: Netherlands Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 125: Netherlands Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 126: Norway Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 127: Norway Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 128: Portugal Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 129: Portugal Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 130: Spain Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 131: Spain Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 132: Spain Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 133: Spain Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 134: Spain Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 135: Spain Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 136: Sweden Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 137: Sweden Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 138: Switzerland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 139: Switzerland Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 140: UK Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 141: UK Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 142: UK Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 143: UK Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 144: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 145: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 146: Eastern Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 147: Eastern Europe Total Population Aged 65 And Above, 2015-2019, Thousands
  • Table 148: Eastern Europe Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 149: Eastern Europe Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 150: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 151: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 152: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 153: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 154: Eastern Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Table 155: Eastern Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 156: Eastern Europe Ophthalmology Drugs Market, 2019,-2022, Growth And Market Share Comparison, By Country
  • Table 157: Eastern Europe Per Capita Average Ophthalmology Drugs Expenditure, By Country, 2019, $
  • Table 158: Czech Republic Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 159: Czech Republic Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 160: Poland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 161: Poland Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 162: Romania Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 163: Romania Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 164: Russia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 165: Russia Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 166: Russia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 167: Russia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 168: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 169: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 170:  North America Public Number Of Ophthalmologists, 2018
  • Table 171:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 172:  North America Private Healthcare Expenditure, 2013-2017, $ Billion
  • Table 173: North America Total Population Aged 65 And Above, 2015-2019
  • Table 174: North America Per Capita Net Disposable Income, 2015-2019, $
  • Table 175: North America Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 176: North America Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 177: North America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 178: North America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 179: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 180: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 181: North America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Table 182: North America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 183: North America Ophthalmology Drugs Market, 2019,-2022, Growth And Market Share Comparison, By Country
  • Table 184: North America Per Capita Average Ophthalmology Drugs Expenditure, By Country, 2019, $
  • Table 185: Canada Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 186: Canada Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 187: Mexico Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 188: Mexico Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 189:  USA Public Number Of Ophthalmologists, 2018
  • Table 190:  USA Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 191:  USA Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 192: USA Total Population Aged 65 And Above, 2015-2019
  • Table 193: USA Per Capita Net Disposable Income, 2015-2019, $
  • Table 194: USA Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 195: USA Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 196: USA Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 197: USA Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 198: USA Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 199: USA Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 200: South America  Per Capita Net Disposable Income, 2015-2019, $
  • Table 201: South America Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 202: South America Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 203: South America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 204: South America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 205: South America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 206: South America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 207: South America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Table 208: South America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 209: South America Ophthalmology Drugs Market, 2019,-2022, Growth And Market Share Comparison, By Country
  • Table 210: South America Per Capita Average Ophthalmology Drugs Expenditure, By Country, 2019, $
  • Table 211: Argentina Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 212: Argentina Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 213: Chile Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 214: Chile Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 215: Colombia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 216: Colombia Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 217: Brazil Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 218: Brazil Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 219: Brazil Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 220: Brazil Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 221: Brazil Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 222: Brazil Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 223: Peru Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 224: Peru Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 225: Venezuela Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 226: Venezuela Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 227: Middle East Per Capita Net Disposable Income, 2015-2019, $
  • Table 228: Eastern Europe Total Population Aged 65 And Above, 2015-2019, Thousands
  • Table 229: Middle East Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 230: Middle East Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 231: Middle East Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 232: Middle East Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 233: Middle East Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 234: Middle East Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 235: Middle East Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Table 236: Middle East Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 237: Middle East Ophthalmology Drugs Market, 2019,-2022, Growth And Market Share Comparison, By Country
  • Table 238: Middle East Per Capita Average Ophthalmology Drugs Expenditure, By Country, 2019, $
  • Table 239: Israel Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 240: Israel Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 241: Saudi Arabia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 242: Saudi Arabia Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 243: Turkey Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 244: Turkey Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 245: UAE Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 246: UAE Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 247: Africa Per Capita Net Disposable Income, 2015-2019, $
  • Table 248: Africa Total Population Aged 65 And Above, 2015-2019, Thousands
  • Table 249: Africa Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 250: Africa Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 251: Africa Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 252: Africa Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 253: Africa Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 254: Africa Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 255: Africa Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Table 256: Africa Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 257: Africa Ophthalmology Drugs Market, 2019,-2022, Growth And Market Share Comparison, By Country
  • Table 258: Africa Per Capita Average Ophthalmology Drugs Expenditure, By Country, 2019, $
  • Table 259: Egypt Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 260: Egypt Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 261: Nigeria Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 262: Nigeria Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 263: South Africa Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 264: South Africa Ophthalmology Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 265: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Table 266: Allergan Plc.– Financial Performance, 2015 - 2019, $ Billion
  • Table 267: Santen Pharmaceutical Co. Ltd.–  Financial Performance, 2014-2018, $ Billion
  • Table 268: Global Pharmaceutical Drugs Market, 2019, Split By Segment
  • Table 269: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Segment
  • Table 270: Global Pharmaceutical Drugs Market, 2019, Split By Region
  • Table 271: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 272: Global Ophthalmology Drugs Market Size Gain ($ Million), 2019 – 2023, By Country
  • Table 273: Global Ophthalmology Drugs Market Size Gain ($ Million), Segmentation By Type Of Drug, 2019 – 2023
  • Table 274: Global Ophthalmology Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2019 – 2023
  • Table 275: Global Ophthalmology Drugs Market Size Gain ($ Million), Segmentation By Type Of Prescription, 2019 – 2023
  • Table 276: Global Ophthalmology Drugs Market Size Gain ($ Million), Segmentation By Drug Variation, 2019 – 2023

List Of Figures

    Figure 1: Global Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 2: Global Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 3: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 4: Global Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Figure 5: Global Ophthalmology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region
  • Figure 6: Global Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 7: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 8: Global Ophthalmology Drugs Market, Segmentation By Type Of Prescription, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 9: Global Ophthalmology Drugs Market, Segmentation By Drug Variation, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 10: Asia-Pacific Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 11: Asia-Pacific Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 12: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 13: Asia- Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 14: Asia-Pacific Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 15: Asia-Pacific Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 16: Asia-Pacific Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 17: Australia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 18: Australia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 19: Australia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 20: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 21: China Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 22: China Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 23: China Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 24: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 25: Hong Kong Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 26: Hong Kong Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 27: India Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 28: India Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 29: India Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 30: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 31: Indonesia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 32: Indonesia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 33: Indonesia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 34: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 35: Japan Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 36: Japan Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 37: Japan Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 38: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 39: Malaysia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 40: Malaysia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 41: New Zealand Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 42: New Zealand Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 43: Philippines Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 44: Philippines Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 45: Singapore Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 46: Singapore Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 47: South Korea Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 48: South Korea Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 49: South Korea Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 50: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 51: Thailand Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 52: Thailand Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 53: Vietnam Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 54: Vietnam Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 55: Western Europe Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 56: Western Europe Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 57: Western Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 58: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 59: Western Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 60: Western Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 61: Western Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 62: Austria Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 63: Austria Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 64: Belgium Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 65: Belgium Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 66: Denmark Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 67: Denmark Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 68: Finland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 69: Finland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 70: France Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 71: France Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 72: France Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 73: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 74: Germany Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 75: Germany Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 76: Germany Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 77: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 78: Ireland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 79: Ireland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 80: Italy Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 81: Italy Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 82: Italy Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 83: Italy Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 84: Netherlands Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 85: Netherlands Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 86: Norway Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 87: Norway Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 88: Portugal Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 89: Portugal Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 90: Spain Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 91: Spain Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 92: Spain Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 93: Spain Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 94: Sweden Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 95: Sweden Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 96: Switzerland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 97: Switzerland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 98: UK Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 99: UK Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 100: UK Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 101: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 102: Eastern Europe Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 103: Eastern Europe Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 104: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 105: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 106: Eastern Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 107: Eastern Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 108: Eastern Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 109: Czech Republic Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 110: Czech Republic Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 111: Poland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 112: Poland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 113: Romania Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 114: Romania Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 115: Russia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 116: Russia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 117: Russia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 118: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 119: North America Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 120: North America Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 121: North America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 122: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 123: North America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 124: North America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 125: North America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 126: Canada Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 127: Canada Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 128: Mexico Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 129: Mexico Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 130: USA Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 131: USA Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 132: USA Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 133: USA Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 134: South America Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 135: South America Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 136: South America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 137: South America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 138: South America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 139: South America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 140: South America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 141: Argentina Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 142: Argentina Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 143: Chile Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 144: Chile Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 145: Colombia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 146: Colombia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 147: Brazil Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 148: Brazil Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 149: Brazil Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 150: Brazil Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 151: Peru Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 152: Peru Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 153: Venezuela Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 154: Venezuela Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 155: Middle East Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 156: Middle East Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 157: Middle East Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 158: Middle East Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 159: Middle East Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 160: Middle East Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 161: Middle East Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 162: Israel Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 163: Israel Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 164: Saudi Arabia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 165: Saudi Arabia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 166: Turkey Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 167: Turkey Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 168: UAE Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 169: UAE Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 170: Africa Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 171: Africa Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 172: Africa Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 173: Africa Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 174: Africa Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 175: Africa Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 176: Africa Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 177: Egypt Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 178: Egypt Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 179: Nigeria Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 180: Nigeria Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 181: South Africa Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 182: South Africa Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 183: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Figure 184: Allergan Plc.– Financial Performance, 2015 - 2019, $ Billion
  • Figure 185: Santen Pharmaceutical Co Ltd.– Financial Performance, 2014-2018, $ Billion
  • Figure 186: Global Pharmaceutical Drugs Market, 2019, Split By Segment
  • Figure 187: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Segment
  • Figure 188: Global Pharmaceutical Drugs Market, 2019, Split By Region
  • Figure 189: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report
Remdesivir Market Global Report 2020-30: COVID 19 Growth and Change
View Report
Biologics Market - By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), Trends, By Key Market Players, And By Region, Opportunities And Strategies – Global Forecast To 2021
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)